Actively Recruiting
Study on How Treating Cartilage Damage Affects Outcomes in Hallux Valgus Surgery for Adults Aged 30 to 60
Led by Tom Lootens · Updated on 2025-03-12
99
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to understand whether treating cartilage damage at the first metatarsophalangeal MTP I joint during surgery for hallux valgus affects patient outcomes. Currently, there are no clear guidelines about managing these cartilage lesions, and it is unknown if treatment impacts recovery or satisfaction after surgery. The study randomly assigns patients into groups based on the presence and severity of cartilage lesions found during surgery. One group includes patients with no or mild lesions who receive no treatment for cartilage damage. Patients with more severe lesions are randomly divided to either receive treatment involving debridement and microfracture of the cartilage or no treatment for these lesions. The surgery and treatment decisions are managed by a single surgeon using imaging tools to assess lesion severity. Participants will be evaluated before surgery and asked to complete questionnaires about pain, function, and satisfaction. Follow-up visits occur at 10 days, 5 weeks, 4 months, and 1 year after surgery to monitor clinical outcomes and repeat questionnaires. The study measures changes in foot function scores, general health, pain levels, and patient satisfaction over time, with a blinded investigator performing follow-ups to ensure unbiased assessments.
CONDITIONS
Brief Title
Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions in Hallux Valgus Surgery
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here